මධ්යස්ථානය සම්බන්ධ කර ගන්නේ කෙසේද
HCP මධ්යස්ථානය
විශ්ව විද්යාල වෛද්ය මධ්යස්ථානයක් ලෙස, Ghent University Hospital පර්යේෂණ, අධ්යාපනය සහ පුහුණුව සඳහා ආයෝජනය කරන අතර Ghent විශ්ව විද්යාලයේ වෛද්ය හා සෞඛ්ය විද්යා පීඨය සමඟ සමීපව කටයුතු කරයි. දෙවැන්න වෛද්ය විද්යාව සහ සෞඛ්ය විද්යාව පිළිබඳ පුළුල් පරාසයක අධ්යයන වැඩසටහන් මෙන්ම ඒ ආශ්රිත පර්යේෂණ ක්රියාකාරකම් ඉදිරිපත් කරයි. මූලික (ජීව) වෛද්ය පර්යේෂණයේ සිට පරිවර්තන සහ සායනික අධ්යයන පර්යේෂණ දක්වා පීඨයේ පර්යේෂණ ඉතා විවිධාකාර වේ. වෛද්යවරුන් සහ සෞඛ්ය සේවා වෘත්තිකයන් අඛණ්ඩව පුහුණු කර ඇති අතර වෛද්ය විද්යාඥයින් ඇතුළු පර්යේෂකයන් නව රෝග විනිශ්චය සහ චිකිත්සක ප්රවේශයන් රාශියක් අධ්යයනය කරයි.
www.uzgent.be සහ www.ugent.be/ge/en හි වැඩි විස්තර
අමතන්න
Ghent University Hospital, Ghent, Belgium
කණ්ඩායම
Pr Bart LEROY
බෙල්ජියම
Pr Elfride DE BAERE
බෙල්ජියම
සායනික පරීක්ෂණ
An Open-Label, Dose Escalation and Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Tolerability of Sepofarsen in Pediatric Subjects G (p.Cys998X) Mutation.
A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).
Extension Study to Study PQ-110-001 (NCT03140969).
A double-masked, randomized, controlled, multiple-dose study to evaluate the efficacy, safety, tolerability and systemic exposure of QR-110 in Subjects with Leber’s Congenital Amaurosis (LCA) due to c.2991+1655A>G mutation (p.Cys998X) in the CEP290 gene (Illuminate).
Efficacy & Safety Study of Bilateral Intravitreal Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year (REFLECT).
Study to Evaluate QR-110 in Subjects With Leber’s Congenital Amaurosis (LCA) Due to the c.2991+1655A>G Mutation (p.Cys998X) in the CEP290 Gene.
Rate of Progression in USH2A Related Retinal Degeneration
Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON).
A Phase I, Randomized, Double Blind, Placebo-controlled, Dose-escalating Clinical Trial With KH176.
Safety and Performance Evaluation of the NR600 System in Subjects With End-stage Inherited Outer Retinal Degenerative Diseases
The Belgian Endothelial Surgical Transplant of the Cornea:Clinical and Patient-reported Outcomes of Descemet Stripping Automated Endothelial Keratoplasty(DSAEK) Versus Descemet Membrane Endothelial Keratoplasty(DMEK)
A Prospective, Open-label, Single-center, Study of the ACUSURGICAL Luca System for Treatment of Vitreoretinal Diseases
Phase I Trial of Gene Vector to Patients with Retinal Disease due toRPE65 mutations
A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis
A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
A Multicenter, Prospective, Longitudinal, Observational Study in Children and Adults With Stargardt Disease Related Atrophy Secondary to Biallelic Mutations in the ABCA4 Gene
A Double-Masked, Randomized, Placebo-Controlled, Paired-Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Due to the c.2991+1655A>G (p.Cys998X) Mutation in the CEP290 Gene